Literature DB >> 19726671

Heparin/heparan sulfate 6-O-sulfatase from Flavobacterium heparinum: integrated structural and biochemical investigation of enzyme active site and substrate specificity.

James R Myette1, Venkataramanan Soundararajan, Zachary Shriver, Rahul Raman, Ram Sasisekharan.   

Abstract

Heparin and heparan sulfate glycosaminoglycans (HSGAGs) comprise a chemically heterogeneous class of sulfated polysaccharides. The development of structure-activity relationships for this class of polysaccharides requires the identification and characterization of degrading enzymes with defined substrate specificity and enzymatic activity. Toward this end, we report here the molecular cloning and extensive structure-function analysis of a 6-O-sulfatase from the Gram-negative bacterium Flavobacterium heparinum. In addition, we report the recombinant expression of this enzyme in Escherichia coli in a soluble, active form and identify it as a specific HSGAG sulfatase. We further define the mechanism of action of the enzyme through biochemical and structural studies. Through the use of defined substrates, we investigate the kinetic properties of the enzyme. This analysis was complemented by homology-based molecular modeling studies that sought to rationalize the substrate specificity of the enzyme and mode of action through an analysis of the active-site topology of the enzyme including identifying key enzyme-substrate interactions and assigning key amino acids within the active site of the enzyme. Taken together, our structural and biochemical studies indicate that 6-O-sulfatase is a predominantly exolytic enzyme that specifically acts on N-sulfated or N-acetylated 6-O-sulfated glucosamines present at the non-reducing end of HSGAG oligosaccharide substrates. This requirement for the N-acetyl or N-sulfo groups on the glucosamine substrate can be explained through eliciting favorable interactions with key residues within the active site of the enzyme. These findings provide a framework that enables the use of 6-O-sulfatase as a tool for HSGAG structure-activity studies as well as expand our biochemical and structural understanding of this important class of enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726671      PMCID: PMC2787378          DOI: 10.1074/jbc.M109.053801

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  SuperPose: a simple server for sophisticated structural superposition.

Authors:  Rajarshi Maiti; Gary H Van Domselaar; Haiyan Zhang; David S Wishart
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.

Authors:  H Nielsen; J Engelbrecht; S Brunak; G von Heijne
Journal:  Protein Eng       Date:  1997-01

3.  Sequential degradation of heparin in Flavobacterium heparinum. Purification and properties of five enzymes involved in heparin degradation.

Authors:  C P Dietrich; M E Silva; Y M Michelacci
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  Heparinase III from Flavobacterium heparinum: cloning and recombinant expression in Escherichia coli.

Authors:  R Godavarti; M Davis; G Venkataraman; C Cooney; R Langer; R Sasisekharan
Journal:  Biochem Biophys Res Commun       Date:  1996-08-23       Impact factor: 3.575

5.  Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis.

Authors:  G Lukatela; N Krauss; K Theis; T Selmer; V Gieselmann; K von Figura; W Saenger
Journal:  Biochemistry       Date:  1998-03-17       Impact factor: 3.162

6.  Purification and characterization of heparin lyases from Flavobacterium heparinum.

Authors:  D L Lohse; R J Linhardt
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

7.  Cloning and expression of heparinase I gene from Flavobacterium heparinum.

Authors:  R Sasisekharan; M Bulmer; K W Moremen; C L Cooney; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Posttranslational formation of formylglycine in prokaryotic sulfatases by modification of either cysteine or serine.

Authors:  T Dierks; C Miech; J Hummerjohann; B Schmidt; M A Kertesz; K von Figura
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

9.  Expression in Escherichia coli, purification and characterization of heparinase I from Flavobacterium heparinum.

Authors:  S Ernst; G Venkataraman; S Winkler; R Godavarti; R Langer; C L Cooney; R Sasisekharan
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

10.  Purification and characterization of the arylsulfatase synthesized by Pseudomonas aeruginosa PAO during growth in sulfate-free medium and cloning of the arylsulfatase gene (atsA).

Authors:  S Beil; H Kehrli; P James; W Staudenmann; A M Cook; T Leisinger; M A Kertesz
Journal:  Eur J Biochem       Date:  1995-04-15
View more
  12 in total

Review 1.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

2.  Glycosaminoglycans in Human and Bovine Serum: Detection of Twenty-Four Heparan Sulfate and Chondroitin Sulfate Motifs Including a Novel Sialic Acid-modified Chondroitin Sulfate Linkage Hexasaccharide.

Authors:  Hong Lu; Lynda M McDowell; Daniel R Studelska; Lijuan Zhang
Journal:  Glycobiol Insights       Date:  2010-02-09

3.  Controlling carrageenan structure using a novel formylglycine-dependent sulfatase, an endo-4S-iota-carrageenan sulfatase.

Authors:  Aurélie Préchoux; Sabine Genicot; Hélène Rogniaux; William Helbert
Journal:  Mar Biotechnol (NY)       Date:  2012-09-26       Impact factor: 3.619

4.  Structural determinants in streptococcal unsaturated glucuronyl hydrolase for recognition of glycosaminoglycan sulfate groups.

Authors:  Yusuke Nakamichi; Yukie Maruyama; Bunzo Mikami; Wataru Hashimoto; Kousaku Murata
Journal:  J Biol Chem       Date:  2010-12-08       Impact factor: 5.157

5.  Hydrolysis of N-alkyl sulfamates and the catalytic efficiency of an S-N cleaving sulfamidase.

Authors:  Danielle C Lohman; Richard Wolfenden; David R Edwards
Journal:  J Org Chem       Date:  2012-02-29       Impact factor: 4.354

6.  Characterization of glycosaminoglycan (GAG) sulfatases from the human gut symbiont Bacteroides thetaiotaomicron reveals the first GAG-specific bacterial endosulfatase.

Authors:  Jonathan E Ulmer; Eric Morssing Vilén; Ramesh Babu Namburi; Alhosna Benjdia; Julie Beneteau; Annie Malleron; David Bonnaffé; Pierre-Alexandre Driguez; Karine Descroix; Gilbert Lassalle; Christine Le Narvor; Corine Sandström; Dorothe Spillmann; Olivier Berteau
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

Review 7.  Heparin and heparan sulfate: analyzing structure and microheterogeneity.

Authors:  Zachary Shriver; Ishan Capila; Ganesh Venkataraman; Ram Sasisekharan
Journal:  Handb Exp Pharmacol       Date:  2012

8.  Heparin/heparan sulfate N-sulfamidase from Flavobacterium heparinum: structural and biochemical investigation of catalytic nitrogen-sulfur bond cleavage.

Authors:  James R Myette; Venkataramanan Soundararajan; Jonathan Behr; Zachary Shriver; Rahul Raman; Ram Sasisekharan
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

9.  Enzyme-Assisted Preparation of Furcellaran-Like κ-/β-Carrageenan.

Authors:  Aurélie Préchoux; Sabine Genicot; Hélène Rogniaux; William Helbert
Journal:  Mar Biotechnol (NY)       Date:  2015-11-19       Impact factor: 3.619

10.  Matching the Diversity of Sulfated Biomolecules: Creation of a Classification Database for Sulfatases Reflecting Their Substrate Specificity.

Authors:  Tristan Barbeyron; Loraine Brillet-Guéguen; Wilfrid Carré; Cathelène Carrière; Christophe Caron; Mirjam Czjzek; Mark Hoebeke; Gurvan Michel
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.